NASDAQ:ONTX
Onconova Therapeutics, Inc.
- Stock
Last Close
1.00
02/04 20:00
Market Cap
14.84M
Beta: 1.77
Volume Today
1.25M
Avg: 588.32K
PE Ratio
−0.75
PFCF: −0.84
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 4.75M - | 800K 83.17% | 11.46M 1,332% | 5.55M 51.59% | 787K 85.81% | 1.23M 56.04% | 2.18M 77.77% | 231K 89.42% | 226K 2.16% | 226K 0% | 226K 0% | |
cost of revenue | 14K - | 14K 0% | -226.00B 1,614,284,200% | |||||||||
gross profit | 4.75M - | 800K 83.17% | 11.46M 1,332% | 5.55M 51.59% | 787K 85.81% | 1.23M 56.04% | 2.18M 77.77% | 231K 89.42% | 212K 8.23% | 212K 0% | 226B 106,603,673.58% | |
selling and marketing expenses | ||||||||||||
general and administrative expenses | 16.79M - | 15.12M 9.97% | 9.53M 36.95% | 9.18M 3.72% | 7.41M 19.32% | 7.59M 2.44% | 8.35M 10.01% | 8.33M 0.23% | 9.43M 13.20% | 8.45M 10.38% | 9.09M 7.66% | |
selling general and administrative expenses | 16.79M - | 15.12M 9.97% | 9.53M 36.95% | 9.18M 3.72% | 7.41M 19.32% | 7.59M 2.44% | 8.35M 10.01% | 8.33M 0.23% | 9.43M 13.20% | 8.45M 10.38% | 9.09M 7.66% | |
research and development expenses | 50.18M - | 49.42M 1.51% | 25.89M 47.61% | 20.07M 22.49% | 19.12M 4.74% | 16.92M 11.48% | 15.54M 8.20% | 16.90M 8.76% | 7.30M 56.82% | 11.41M 56.31% | 11.43M 0.21% | |
other expenses | 63K - | -50K 179.37% | -35K 30% | 30K - | 1.15M 3,736.67% | 143K 87.58% | 48K 66.43% | 12K 75% | 663K 5,425% | 1.35M 103.62% | ||
cost and expenses | 66.97M - | 64.54M 3.63% | 35.43M 45.11% | 29.25M 17.44% | 26.52M 9.32% | 24.51M 7.59% | 23.88M 2.56% | 25.22M 5.62% | 16.72M 33.71% | 19.85M 18.72% | 20.52M 3.38% | |
operating expenses | 66.97M - | 64.54M 3.63% | 35.43M 45.11% | 29.25M 17.44% | 26.52M 9.32% | 24.51M 7.59% | 23.88M 2.56% | 25.22M 5.62% | 16.72M 33.71% | 19.85M 18.72% | 20.52M 3.38% | |
interest expense | 4K - | 2K 50% | -14.00K - | |||||||||
ebitda | -62.16M - | -63.71M 2.50% | -23.82M 62.61% | -27.66M 16.10% | -27.36M 1.06% | -24.88M 9.08% | -21.76M 12.53% | -24.79M 13.89% | -16.82M 32.15% | -19.63M 16.71% | -20.28M 3.34% | |
operating income | -62.22M - | -63.74M 2.45% | -23.97M 62.39% | -23.70M 1.12% | -25.74M 8.58% | -23.28M 9.54% | -21.70M 6.80% | -24.99M 15.18% | -16.50M 34.00% | -19.63M 18.98% | -20.30M 3.42% | |
depreciation and amortization | 446K - | 434K 2.69% | 150K 65.44% | 96K 36% | 88K 8.33% | 55K 37.50% | -63K 214.55% | 208K 430.16% | -321K 254.33% | 14K 104.36% | 16K 14.29% | |
total other income expenses net | 105K - | -32K 130.48% | -35K 9.38% | 4.05M 11,671.43% | 1.66M 59.06% | 2.75M 65.74% | 206K 92.50% | -160K 177.67% | 333K 308.13% | 663K 99.10% | 1.35M 103.62% | |
income before tax | -62.12M - | -63.78M 2.66% | -24.01M 62.36% | -19.65M 18.14% | -24.08M 22.52% | -20.53M 14.72% | -21.49M 4.67% | -25.15M 17.03% | -16.16M 35.74% | -18.96M 17.33% | -18.95M 0.08% | |
income tax expense | 435K - | 19K 95.63% | 16K 15.79% | 14K 12.50% | 13K 7.14% | -124K 1,053.85% | 10K 108.06% | 4K 60% | -335K 8,475% | -663.00K 97.91% | ||
net income | -62.54M - | -63.68M 1.82% | -23.98M 62.35% | -19.67M 17.98% | -24.09M 22.50% | -20.57M 14.61% | -21.50M 4.52% | -25.16M 16.99% | -15.83M 37.08% | -18.30M 15.62% | -18.95M 3.54% | |
weighted average shs out | 4.71K - | 9.62K 104.40% | 10.11K 5.02% | 19.67K 94.67% | 40.00K 103.33% | 274.94K 587.33% | 958.97K 248.79% | 11.60M 1,109.89% | 16.83M 45.08% | 20.91M 24.22% | 20.99M 0.39% | |
weighted average shs out dil | 4.71K - | 9.62K 104.40% | 10.11K 5.02% | 19.67K 94.68% | 40.00K 103.32% | 274.94K 587.33% | 958.97K 248.79% | 11.60M 1,109.89% | 16.83M 45.08% | 20.91M 24.22% | 20.99M 0.39% | |
eps | -13.28K - | -6.62K 50.18% | -2.37K 64.15% | -999.64 57.87% | -602.28 39.75% | -74.83 87.58% | -22.42 70.04% | -2.17 90.32% | -0.94 56.68% | -0.88 6.38% | -0.90 2.27% | |
epsdiluted | -13.28K - | -6.62K 50.18% | -2.37K 64.15% | -999.64 57.87% | -602.28 39.75% | -74.83 87.58% | -22.42 70.04% | -2.17 90.32% | -0.94 56.68% | -0.88 6.38% | -0.90 2.27% |
All numbers in USD (except ratios and percentages)